Fig. 3. Representative examples of the relationship between metabolic parameters and overall survival. (A) Representative 18F-FDG PET/CT images of a 52-yr-old female patient with middle esophageal cancer (T3N0, stage IIB) exhibiting a TLG of 673.92, an MTV of 93.6 cm3, and a SUVmax of 21.7. She exhibited progressive disease after 5-fluorouracil/cisplatin chemoradiotherapy and lived for 5.6 months after the diagnosis. (B) Representative 18F-FDG PET/CT images of a 79-yr-old male patient with lower esophageal cancer (T2N1, stage IIB) exhibiting a TLG of 68.64, an MTV of 15.6 cm3, and a SUVmax of 10.5. He exhibited stable disease after radiotherapy alone and lived for 61.8 months after the diagnosis.
